HeartBeam, Inc. (BEATW)
USD 0.5
(2.12%)
USD 0.5
(2.12%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.19 Million USD | -28.29% |
| 2022 | 1.66 Million USD | 183.16% |
| 2021 | 588 Thousand USD | -87.84% |
| 2020 | 4.83 Million USD | 29.51% |
| 2019 | 3.73 Million USD | -98.65% |
| 2018 | 276.31 Million USD | 0.53% |
| 2017 | 274.85 Million USD | 357.56% |
| 2016 | 60.07 Million USD | 24.58% |
| 2015 | 48.21 Million USD | -21.09% |
| 2014 | 61.1 Million USD | 194.94% |
| 2013 | 20.71 Million USD | 3.52% |
| 2012 | 20.01 Million USD | 17.87% |
| 2011 | 16.97 Million USD | -21.99% |
| 2010 | 21.76 Million USD | 14.73% |
| 2009 | 18.96 Million USD | 21.16% |
| 2008 | 15.65 Million USD | -87.95% |
| 2007 | 129.9 Million USD | 250.84% |
| 2006 | 37.02 Million USD | 0.0% |
| 2004 | 25.56 Million USD | 80.66% |
| 2003 | 14.15 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.42 Million USD | 29.44% |
| 2024 Q1 | 1.09 Million USD | -8.12% |
| 2023 Q3 | 1.01 Million USD | 78.77% |
| 2023 Q1 | 2.32 Million USD | 39.34% |
| 2023 Q4 | 1.19 Million USD | 17.17% |
| 2023 FY | 1.19 Million USD | -28.29% |
| 2023 Q2 | 570 Thousand USD | -75.43% |
| 2022 Q2 | 770 Thousand USD | 49.81% |
| 2022 Q1 | 514 Thousand USD | -12.59% |
| 2022 Q4 | 1.66 Million USD | 78.65% |
| 2022 Q3 | 932 Thousand USD | 21.04% |
| 2022 FY | 1.66 Million USD | 183.16% |
| 2021 Q2 | 4.78 Million USD | -6.12% |
| 2021 Q3 | 6.14 Million USD | 28.48% |
| 2021 Q4 | 588 Thousand USD | -90.44% |
| 2021 FY | 588 Thousand USD | -87.84% |
| 2021 Q1 | 5.09 Million USD | 5.4% |
| 2020 Q3 | 340.71 Million USD | 4.57% |
| 2020 Q2 | 325.82 Million USD | -10.35% |
| 2020 FY | 4.83 Million USD | 29.51% |
| 2020 Q1 | 363.42 Million USD | 14.0% |
| 2020 Q4 | 4.83 Million USD | -98.58% |
| 2019 Q4 | 318.8 Million USD | 1.12% |
| 2019 Q3 | 315.25 Million USD | -0.65% |
| 2019 Q2 | 317.32 Million USD | -2.95% |
| 2019 FY | 3.73 Million USD | -98.65% |
| 2019 Q1 | 326.98 Million USD | 18.34% |
| 2018 Q1 | 271.67 Million USD | -1.16% |
| 2018 FY | 276.31 Million USD | 0.53% |
| 2018 Q4 | 276.31 Million USD | -0.85% |
| 2018 Q3 | 278.69 Million USD | 1.28% |
| 2018 Q2 | 275.17 Million USD | 1.29% |
| 2017 Q4 | 274.85 Million USD | 8.9% |
| 2017 Q3 | 252.39 Million USD | 341.44% |
| 2017 Q1 | 61.67 Million USD | 2.66% |
| 2017 FY | 274.85 Million USD | 357.56% |
| 2017 Q2 | 57.17 Million USD | -7.29% |
| 2016 Q4 | 60.07 Million USD | -14.4% |
| 2016 Q1 | 48.27 Million USD | 0.11% |
| 2016 FY | 60.07 Million USD | 24.58% |
| 2016 Q2 | 67.69 Million USD | 40.23% |
| 2016 Q3 | 70.17 Million USD | 3.67% |
| 2015 FY | 48.21 Million USD | -21.09% |
| 2015 Q1 | 53.11 Million USD | -13.08% |
| 2015 Q4 | 48.21 Million USD | -5.32% |
| 2015 Q3 | 50.92 Million USD | -3.42% |
| 2015 Q2 | 52.73 Million USD | -0.72% |
| 2014 Q4 | 61.1 Million USD | 12.81% |
| 2014 Q2 | 55.7 Million USD | 30.78% |
| 2014 Q1 | 42.59 Million USD | 105.62% |
| 2014 FY | 61.1 Million USD | 194.94% |
| 2014 Q3 | 54.16 Million USD | -2.78% |
| 2013 FY | 20.71 Million USD | 3.52% |
| 2013 Q1 | 20.24 Million USD | 1.16% |
| 2013 Q2 | 22.34 Million USD | 10.39% |
| 2013 Q3 | 22.93 Million USD | 2.63% |
| 2013 Q4 | 20.71 Million USD | -9.67% |
| 2012 Q1 | 15.5 Million USD | -8.65% |
| 2012 FY | 20.01 Million USD | 17.87% |
| 2012 Q3 | 21.05 Million USD | 31.74% |
| 2012 Q2 | 15.98 Million USD | 3.04% |
| 2012 Q4 | 20.01 Million USD | -4.94% |
| 2011 FY | 16.97 Million USD | -21.99% |
| 2011 Q4 | 16.97 Million USD | -13.45% |
| 2011 Q2 | 19.21 Million USD | 0.59% |
| 2011 Q1 | 19.1 Million USD | -12.22% |
| 2011 Q3 | 19.61 Million USD | 2.08% |
| 2010 Q4 | 21.76 Million USD | 40.43% |
| 2010 Q2 | 15.77 Million USD | -5.46% |
| 2010 Q3 | 15.49 Million USD | -1.72% |
| 2010 Q1 | 16.68 Million USD | -12.06% |
| 2010 FY | 21.76 Million USD | 14.73% |
| 2009 Q1 | 16.84 Million USD | 7.6% |
| 2009 Q3 | 14.94 Million USD | 5.55% |
| 2009 Q2 | 14.16 Million USD | -15.94% |
| 2009 FY | 18.96 Million USD | 21.16% |
| 2009 Q4 | 18.96 Million USD | 26.92% |
| 2008 Q2 | 15.58 Million USD | -19.71% |
| 2008 Q4 | 15.65 Million USD | -31.53% |
| 2008 Q1 | 19.41 Million USD | -85.05% |
| 2008 FY | 15.65 Million USD | -87.95% |
| 2008 Q3 | 22.86 Million USD | 46.68% |
| 2007 Q4 | 129.9 Million USD | 0.0% |
| 2007 Q2 | 147.9 Million USD | 0.0% |
| 2007 FY | 129.9 Million USD | 250.84% |
| 2006 FY | 37.02 Million USD | 0.0% |
| 2006 Q4 | 37.02 Million USD | 0.0% |
| 2004 FY | 25.56 Million USD | 80.66% |
| 2003 FY | 14.15 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Augmedix, Inc. | 43.39 Million USD | 97.248% |
| OneMedNet Corporation | 13.32 Million USD | 91.038% |
| Minerva Surgical, Inc. | 51.71 Million USD | 97.691% |
| CareCloud, Inc. | 37.79 Million USD | 96.841% |
| CareCloud, Inc. | 37.79 Million USD | 96.841% |
| HealthEquity, Inc. | 1.2 Billion USD | 99.901% |
| iCoreConnect Inc. | 11.24 Million USD | 89.379% |
| Progyny, Inc. | 203.19 Million USD | 99.412% |
| Renalytix Plc | 15.82 Million USD | 92.455% |
| Schrödinger, Inc. | 254.39 Million USD | 99.531% |
| Simulations Plus, Inc. | 14.2 Million USD | 91.596% |
| SOPHiA GENETICS SA | 54.71 Million USD | 97.818% |
| Omnicell, Inc. | 1.03 Billion USD | 99.885% |
| BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 99.977% |
| Streamline Health Solutions, Inc. | 22.92 Million USD | 94.792% |
| Inovalon Holdings, Inc. | 1.26 Billion USD | 99.905% |
| Ontrak, Inc. | 5.57 Million USD | 78.583% |
| Nutex Health, Inc. | 319.13 Million USD | 99.626% |
| GE HealthCare Technologies Inc. | 25.14 Billion USD | 99.995% |
| Sharecare, Inc. | 125.56 Million USD | 99.049% |
| Aclarion, Inc. | 3.18 Million USD | 62.544% |
| CareMax, Inc. | 561.85 Million USD | 99.787% |
| Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -547.681% |
| Forian Inc. | 33.19 Million USD | 96.403% |
| Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -547.681% |
| GeneDx Holdings Corp. | 245.65 Million USD | 99.514% |
| SCWorx Corp. | 2.42 Million USD | 50.758% |
| Definitive Healthcare Corp. | 626.72 Million USD | 99.809% |
| 10x Genomics, Inc. | 224.1 Million USD | 99.467% |
| Zhongchao Inc. | 3.37 Million USD | 64.659% |
| Accolade, Inc. | 342.68 Million USD | 99.652% |
| MSP Recovery, Inc. | 1.74 Billion USD | 99.931% |
| R1 RCM Inc. | 2.2 Billion USD | 99.946% |
| Spok Holdings, Inc. | 63.91 Million USD | 98.132% |
| Privia Health Group, Inc. | 392.51 Million USD | 99.696% |
| EUDA Health Holdings Limited | 8.79 Million USD | 86.42% |
| TruBridge, Inc. | 247.8 Million USD | 99.518% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 99.977% |
| Sharecare, Inc. | 125.56 Million USD | 99.049% |
| Health Catalyst, Inc. | 334.89 Million USD | 99.643% |
| GoodRx Holdings, Inc. | 826.84 Million USD | 99.856% |
| Premier, Inc. | 1.46 Billion USD | 99.919% |
| HealthStream, Inc. | 159.19 Million USD | 99.25% |
| Certara, Inc. | 516.29 Million USD | 99.769% |
| GeneDx Holdings Corp. | 245.65 Million USD | 99.514% |
| Ontrak, Inc. | 5.57 Million USD | 78.583% |
| SHL Telemedicine Ltd. | 36.58 Million USD | 96.737% |
| CareCloud, Inc. | 37.79 Million USD | 96.841% |
| EUDA Health Holdings Limited | 8.79 Million USD | 86.42% |
| HeartBeam, Inc. | 1.19 Million USD | 0.0% |
| Mangoceuticals, Inc. | 276.03 Thousand USD | -332.548% |
| CareMax, Inc. | 561.85 Million USD | 99.787% |
| Healthcare Triangle, Inc. | 9.51 Million USD | 87.446% |
| National Research Corporation | 73.48 Million USD | 98.375% |
| Aclarion, Inc. | 3.18 Million USD | 62.544% |
| OptimizeRx Corporation | 56.82 Million USD | 97.899% |